Pjano Melisa Ahmedbegovic, Pidro Ajla, Biscevic Alma, Grisevic Senad, Pandzic Bojana, Cerovic Vesna
Eye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
University Eye Hospital "Svjetlost", Zagreb, Croatia.
Med Arch. 2017 Apr;71(2):93-96. doi: 10.5455/medarh.2017.71.93-96.
The aim was to examine efficacy and safety after Implantable Collamer Lens (ICL) implantation for correction of myopia et myopic astigmatism.
This prospective clinical study included 28 eyes of 16 patients which underwent implantation of ICL for correction of myopia up to -18,00 diopters (D) and myopic astigmatism up to -6,00 D in the Eye Clinic Svjetlost Sarajevo, from January 2013 to January 2016. Uncorrected distance visual acuity (UDVA), spherical equivalent (SE), corrected distance visual acuity (CDVA), intraocular pressure (IOP), endothelial cell (EC) density were evaluated at one, six and twelve months. For statistical analysis SPSS for Windows and Microsoft Excel were used.
Out of 16 patients, with mean age of 28,21 ± 4,06 years, 12 of them had binocular and 4 of them had monocular procedure. After 12 months mean UDVA was 0,76 ± 0,16 compared to UDVA 0,04 ± 0,03 preoperatively. Mean SE preoperatively was -0,21 ± 0,27 D compared to -9,52 ± 3,69 D preoperatively. At 12 months one eye (3,57%) lost 2 Snellen lines. In this study 8 eyes (28,57%) gained 1 line, 5 eyes gained (17,56%) 2 lines, and 3 eyes (10,72%) gained 3 lines. EC loss was 5,50±4.71% after 12 months. There was no significant change of IOP by the end of 12 months follow up period. One haptic crack was reported as the only intraoperative complication. Three postoperative complications were: two lens rotations and one retinal detachment.
Implantation of ICL is an effective and safe method for reducing or correcting myopia and myopic astigmatism.
本研究旨在探讨可植入式角膜接触镜（ICL）植入术矫正近视及近视散光后的疗效和安全性。
这项前瞻性临床研究纳入了2013年1月至2016年1月期间在萨拉热窝Svjetlost眼科诊所接受ICL植入术的16例患者的28只眼睛，这些患者的近视度数最高达-18.00屈光度（D），近视散光最高达-6.00D。在术后1个月、6个月和12个月时评估裸眼远视力（UDVA）、等效球镜度（SE）、矫正远视力（CDVA）、眼压（IOP）、内皮细胞（EC）密度。使用SPSS for Windows和Microsoft Excel进行统计分析。
16例患者的平均年龄为28.21±4.06岁，其中12例行双眼手术，4例行单眼手术。术后12个月时，平均UDVA为0.76±0.16，而术前UDVA为0.04±0.03。术前平均SE为-0.21±0.27D，术后为-9.52±3.69D。术后12个月时，有1只眼（3.57%）视力下降2行。在本研究中，8只眼（28.57%）视力提高1行，5只眼（17.56%）提高2行，3只眼（10.72%）提高3行。术后12个月时内皮细胞损失为5.50±4.71%。在12个月的随访期结束时，眼压无显著变化。术中唯一的并发症是1例触觉裂纹。术后并发症有3例：2例晶状体旋转和1例视网膜脱离。
ICL植入术是降低或矫正近视及近视散光的一种有效且安全的方法。
